Joel Greenblatt's ROIV Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 330,475 shares of Roivant Sciences Ltd. (ROIV) worth $5 M, representing 0.02% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in ROIV for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 291,326 shares. Largest reduction occurred in Q3 2024, reducing 510 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2024 | +39,537 | New Buy | 39,537 | $10.57 |
| Q3 2024 | -510 | Reduce 1.29% | 39,027 | $11.54 |
| Q2 2025 | +122 | Add 0.31% | 39,149 | $11.27 |
| Q3 2025 | +291,326 | Add 744.15% | 330,475 | $15.13 |
Joel Greenblatt's Roivant Sciences Investment FAQs
Joel Greenblatt first purchased Roivant Sciences Ltd. (ROIV) in Q2 2024, acquiring 39,537 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Roivant Sciences Ltd. (ROIV) for 6 quarters since Q2 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Roivant Sciences Ltd. (ROIV) was in Q3 2025, adding 330,475 shares worth $5 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 330,475 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $5 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.02% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Roivant Sciences Ltd. (ROIV) was 330,475 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.